IDYA IDEAYA Biosciences Inc

Price (delayed)

$22.69

Market cap

$746.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.18

Enterprise value

$616.13M

Highlights
IDEAYA Biosciences's equity has surged by 162% YoY and by 18% QoQ
The EPS has surged by 55% year-on-year and by 16% since the previous quarter
The quick ratio has decreased by 29% YoY but it has increased by 14% from the previous quarter

Key stats

What are the main financial stats of IDYA
Market
Shares outstanding
32.91M
Market cap
$746.64M
Enterprise value
$616.13M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.14
Price to sales (P/S)
26.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
23
Earnings
Revenue
$26.79M
EBIT
-$31.47M
EBITDA
-$30.05M
Free cash flow
$49.79M
Per share
EPS
-$1.18
Free cash flow per share
$1.57
Book value per share
$7.23
Revenue per share
$0.84
TBVPS
$10.27
Balance sheet
Total assets
$326.1M
Total liabilities
$92.97M
Debt
$6.35M
Equity
$233.13M
Working capital
$272.03M
Liquidity
Debt to equity
0.03
Current ratio
8.53
Quick ratio
8.45
Net debt/EBITDA
4.34
Margins
EBITDA margin
-112.2%
Gross margin
100%
Net margin
-117.5%
Operating margin
-119.5%
Efficiency
Return on assets
-11.3%
Return on equity
-15.8%
Return on invested capital
-22.4%
Return on capital employed
-10.9%
Return on sales
-117.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDYA stock price

How has the IDEAYA Biosciences stock price performed over time
Intraday
-0.22%
1 week
8.62%
1 month
15.71%
1 year
59.12%
YTD
62.07%
QTD
-3.45%

Financial performance

How have IDEAYA Biosciences's revenue and profit performed over time
Revenue
$26.79M
Gross profit
$26.79M
Operating income
-$32M
Net income
-$31.47M
Gross margin
100%
Net margin
-117.5%
The revenue is up by 37% since the previous quarter
The company's gross profit rose by 37% QoQ
IDEAYA Biosciences's operating margin has increased by 34% from the previous quarter
The company's net margin rose by 33% QoQ

Growth

What is IDEAYA Biosciences's growth rate over time

Valuation

What is IDEAYA Biosciences stock price valuation
P/E
N/A
P/B
3.14
P/S
26.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
23
The EPS has surged by 55% year-on-year and by 16% since the previous quarter
IDEAYA Biosciences's equity has surged by 162% YoY and by 18% QoQ
The stock's P/B is 43% above its last 4 quarters average of 2.2
The revenue is up by 37% since the previous quarter

Efficiency

How efficient is IDEAYA Biosciences business performance
The ROA has soared by 70% YoY and by 28% from the previous quarter
IDYA's ROIC has soared by 65% YoY and by 24% from the previous quarter
The company's return on equity has surged by 63% YoY and by 25% QoQ
The return on sales is up by 33% since the previous quarter

Dividends

What is IDYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDYA.

Financial health

How did IDEAYA Biosciences financials performed over time
IDYA's current ratio is down by 30% YoY but it is up by 14% QoQ
The quick ratio has decreased by 29% YoY but it has increased by 14% from the previous quarter
The company's debt is 97% lower than its equity
IDEAYA Biosciences's equity has surged by 162% YoY and by 18% QoQ
IDEAYA Biosciences's debt to equity has shrunk by 57% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.